Your browser is no longer supported. Please, upgrade your browser.
Settings
BIOC Biocept, Inc. daily Stock Chart
BIOC [NASD]
Biocept, Inc.
Index- P/E- EPS (ttm)-7.15 Insider Own0.23% Shs Outstand20.20M Perf Week17.71%
Market Cap22.83M Forward P/E- EPS next Y-0.49 Insider Trans0.00% Shs Float18.83M Perf Month37.80%
Income-24.90M PEG- EPS next Q-0.19 Inst Own12.50% Short Float5.27% Perf Quarter0.89%
Sales3.50M P/S6.52 EPS this Y56.90% Inst Trans181.18% Short Ratio0.23 Perf Half Y38.26%
Book/sh1.43 P/B0.79 EPS next Y44.30% ROA-186.00% Target Price4.42 Perf Year-85.46%
Cash/sh0.73 P/C1.54 EPS next 5Y40.00% ROE-348.70% 52W Range0.66 - 12.15 Perf YTD31.38%
Dividend- P/FCF- EPS past 5Y51.60% ROI-527.40% 52W High-90.70% Beta2.00
Dividend %- Quick Ratio2.60 Sales past 5Y89.10% Gross Margin- 52W Low71.73% ATR0.14
Employees42 Current Ratio2.70 Sales Q/Q25.00% Oper. Margin- RSI (14)52.71 Volatility7.45% 14.03%
OptionableNo Debt/Eq0.11 EPS Q/Q78.80% Profit Margin- Rel Volume1.53 Prev Close1.02
ShortableYes LT Debt/Eq0.07 EarningsMar 28 AMC Payout- Avg Volume4.33M Price1.13
Recom2.00 SMA20-3.78% SMA508.46% SMA200-28.00% Volume6,621,326 Change10.78%
Nov-14-17Reiterated Chardan Capital Markets Buy $2.50 → $1.50
Jun-02-17Initiated Chardan Capital Markets Buy $2.50
Jun-06-16Initiated ROTH Capital Buy $1.20
Aug-19-15Initiated H.C. Wainwright Buy $4
Jun-03-14Initiated Aegis Capital Buy $16
Jun-18-19 08:05AM  Biocept Announces Commercial Launch of Target Selector NGS Breast Panel, the Company's Second Multi-Gene Tumor-Specific Panel PR Newswire +10.78%
Jun-03-19 08:05AM  Biocept to Present at the 9th Annual LD Micro Invitational Conference on June 4 PR Newswire
May-28-19 08:05AM  Biocept Awarded Patent in China for its Circulating Tumor Cell Platform Expanding Intellectual Property Estate to 33 Issued Patents Globally PR Newswire +11.29%
May-20-19 03:07PM  Biocept's stock soars on heavy volume after commercial launch of liquid biopsy test for lung cancer MarketWatch +95.12%
08:05AM  Biocept Announces Clinical Validation and Commercial Launch of its Target Selector Multi-Gene Liquid Biopsy Panel for Lung Cancer PR Newswire
May-08-19 04:05PM  Biocept Reports First Quarter 2019 Financial Results PR Newswire
May-01-19 08:05AM  Biocept to Release First Quarter 2019 Financial Results and Host Investor Conference Call on May 8, 2019 PR Newswire
Mar-28-19 04:05PM  Biocept Reports 2018 Fourth Quarter and Full Year Financial Results PR Newswire
Mar-26-19 08:05AM  Biocept Broadens Commercial Focus of its Target Selector Liquid Biopsy Platform to Include Urology Market Segment PR Newswire +19.42%
Mar-21-19 08:05AM  Biocept to Release 2018 Fourth Quarter and Full Year Financial Results and Host Investor Conference Call on March 28, 2019 PR Newswire
Mar-18-19 08:05AM  Biocept Awarded Patent in Japan for the Capture of Rare Cells Including CTCs from Any Biological Sample of Interest with A Microchannel Device PR Newswire -7.69%
08:00AM  Biocept, Potential Near-Term Catalysts for Biocept ACCESSWIRE
Mar-15-19 09:00AM  Biocept Announces Pricing of $8.2 Million Registered Direct Offering PR Newswire -25.95%
Mar-13-19 08:05AM  Biocept Expands its Pathology Partnership Offering for Liquid Biopsy with the Addition of Several Key Services PR Newswire
Mar-04-19 08:05AM  Biocept's Liquid Biopsy Test for ESR1 Biomarker Detection to be Featured in Poster Presentation at the 2019 AACR Annual Meeting PR Newswire
Feb-27-19 10:00AM  Four Healthcare Stocks Getting A Boost On Wednesday ACCESSWIRE
08:05AM  Biocept and Providence Saint John's Health Center Collaborate to Evaluate Cerebrospinal Fluid for Use with Liquid Biopsy Testing in Metastatic Cancer PR Newswire
Feb-20-19 08:05AM  Biocept Issues Letter to Stockholders PR Newswire
Feb-13-19 09:34AM  What Makes Biocept (BIOC) a New Buy Stock Zacks
Feb-08-19 08:45AM  Biocept Announces Pricing of $7.5 Million Underwritten Public Offering PR Newswire -47.29%
Feb-07-19 08:42AM  Biocept Announces Agreement with Agiomix FZ-LLC for Target Selector Liquid Biopsy Kits PR Newswire +7.98%
Feb-05-19 08:05AM  Published Case Series Indicates the Ability of Biocept's Liquid Biopsy Testing to Identify Actionable Biomarkers When Tissue Biopsy Is Unsuccessful PR Newswire
Jan-30-19 08:20AM  Biocept, Inc., Pipeline Review, Upcoming Catalysts and Milestones ACCESSWIRE
Jan-28-19 08:05AM  Biocept Launches Liquid Biopsy Kits Intended to Broaden Use of its Proprietary Technology Platform for High Sensitivity Detection of Circulating Tumor DNA PR Newswire +8.76%
Jan-22-19 02:45PM  Should You Worry About Biocept, Inc.s (NASDAQ:BIOC) CEO Salary Level? Simply Wall St. -14.85%
Jan-18-19 09:00AM  Biocept Announces Pricing of $2.2 Million Registered Direct Offering PR Newswire -24.42%
Jan-17-19 07:55AM  Today's Research Reports on Trending Tickers: Adamis Pharmaceuticals and Biocept ACCESSWIRE +29.49%
Dec-19-18 06:55AM  Today's Research Reports on Trending Tickers: Biogen and Biocept ACCESSWIRE -29.82%
Dec-18-18 08:05AM  Biocept and Prognos Enter Into Partnership to Apply Artificial Intelligence in Order to Help Pharmaceutical and Life Sciences Companies Optimize Commercialization of Biomarker-Targeted Therapies in Oncology PR Newswire +66.28%
Nov-29-18 08:09AM  The Daily Biotech Pulse: Twist In Protagonist Tale, Catalyst's Autoimmune Disorder Drug Approved Benzinga
Nov-20-18 01:19PM  What Kind Of Shareholder Appears On The Biocept Incs (NASDAQ:BIOC) Shareholder Register? Simply Wall St.
Nov-13-18 04:05PM  Biocept Reports Third Quarter 2018 Financial Results PR Newswire
Nov-06-18 08:05AM  Biocept to Release Third Quarter 2018 Financial Results and Host Investor Conference Call on November 13, 2018 PR Newswire -6.73%
Nov-05-18 08:05AM  Biocept Announces New Executive Hires to its Sales and Marketing Organization PR Newswire +5.05%
Nov-01-18 11:28AM  Biocept (BIOC) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks +5.79%
Oct-23-18 08:05AM  Biocept to Present at the Dawson James Securities Small Cap Growth Conference on October 30 PR Newswire
Oct-18-18 08:05AM  Biocept Obtains Japanese Patent for its Target Selector Oncogene Mutation Enrichment and Detection Platform PR Newswire
Sep-25-18 08:05AM  Biocept to Present at The MicroCap Conference in New York on October 2 PR Newswire
Sep-24-18 08:05AM  Biocept Awarded Patent in Hong Kong for its Target Selector Platform Using Antibodies and a Microchannel to Perform Liquid Biopsy PR Newswire
Sep-21-18 07:00AM  Biocept Announces Pricing of $2.5 Million Registered Direct Offering Priced at Market PR Newswire -11.98%
Sep-10-18 08:05AM  Biocept Names Edwin C. Hendrick as Senior Vice President, Chief Commercial Officer PR Newswire
Sep-06-18 08:05AM  Biocept's Target Selector Platform Featured in Two Poster Presentations at the IASLC 19th World Conference on Lung Cancer PR Newswire
Aug-23-18 10:30AM  Highmark Health's VITAL Innovation Program testing benefits of Biocept's liquid biopsy platform for improving outcomes and lowering costs of treatment for patients with non-small cell lung cancer PR Newswire +18.33%
Aug-15-18 08:48AM  The Daily Biotech Pulse: Vertex Awaits FDA Verdict, Strongbridge Falls On Offering, ReShape's Woes Continue Benzinga -12.88%
Aug-14-18 04:05PM  Biocept Reports Second Quarter 2018 Financial Results PR Newswire -6.17%
Aug-09-18 04:05PM  Biocept to Release Second Quarter 2018 Financial Results and Host Investor Conference Call on August 14, 2018 PR Newswire
08:05AM  Biocept Announces $11.6 Million in Expected Gross Proceeds from Recently Expired Rights Offering PR Newswire
Aug-06-18 08:05AM  Biocept Announces Agreement with Managed Care Plan to Study the Benefits of Implementing Liquid Biopsy to Improve Patient Outcomes and Lower Healthcare Costs PR Newswire
Aug-02-18 08:05AM  Biocept Awarded Patent in Canada for its Target Selector CTC Platform PR Newswire
Jul-31-18 08:05AM  European Patent Granted for Biocept's Target Selector Oncogene Mutation Enrichment and Detection Platform PR Newswire
Jul-23-18 08:05AM  Biocept and UC San Diego Moores Cancer Center Announce Collaboration to Study Feasibility of Liquid Biopsy to Predict Disease Recurrence in Solid Tumors and Response to Therapy PR Newswire
Jul-19-18 09:00AM  Biocept Reminds Investors of Today's Deadline to be a Shareholder of Record PR Newswire
Jul-16-18 08:39AM  Biocept, Inc. (BIOC) Soars: Stock Adds 9.8% in Session Zacks
08:10AM  Today's Research Reports on Stocks to Watch: Biocept and Johnson and Johnson ACCESSWIRE
Jul-13-18 04:49PM  Why RH, Biocept, and Lowe's Jumped Today Motley Fool +9.77%
03:46PM  BIOC: Whats Going on With Biocept Stock? InvestorPlace
01:02PM  Why Biocept, Inc. Is Rebounding Big-Time Today Motley Fool
11:00AM  Biocept Rallies On Marketing Agreement For Proprietary Liquid Biopsy Tests Benzinga
08:05AM  Biocept Enters into Agreement with Alliance Global FZ to Market and Distribute Liquid Biopsy Testing in the Middle East, Southeast Asia, and Africa Region PR Newswire
Jul-12-18 12:26PM  Why Biocept, Inc. Stock Is Plunging Today Motley Fool -17.30%
08:00AM  Today's Research Reports on Trending Tickers: Biocept and Myriad Genetics ACCESSWIRE
Jul-11-18 09:00AM  Biocept Informs Stockholders of Key Dates and Terms Related to Announced Rights Offering PR Newswire +115.22%
Jun-25-18 08:05AM  Biocept Highlights Recent Progress and Outlines Near-Term Strategic Priorities in CEO Letter to Stockholders PR Newswire
Jun-20-18 07:15AM  Free Stock Performance Review on Agilent Technologies and Three Additional Medical Research Stocks ACCESSWIRE
Jun-18-18 08:05AM  Published Case Report Demonstrates the Clinical Utility of Biocept's CTC Platform in the Management of Patients with Metastatic Breast Cancer PR Newswire
Jun-11-18 08:05AM  VWR, Part of Avantor, and Biocept Announce the Launch of CEE-Sure Blood Collection Tubes for cfDNA and CTCs PR Newswire
May-29-18 08:05AM  Biocept to Present at the 8th Annual LD Micro Invitational Conference on June 5 PR Newswire
May-17-18 08:30AM  Agilent Technologies and Three More Healthcare Stocks Under Our Scanner ACCESSWIRE +5.21%
May-15-18 04:05PM  Biocept Reports First Quarter 2018 Financial Results PR Newswire
May-08-18 08:05AM  Biocept to Release First Quarter 2018 Financial Results and Host Investor Conference Call on May 15, 2018 PR Newswire
May-01-18 08:05AM  Case Report in Journal of Thoracic Oncology Demonstrates the Clinical Utility of Biocept's Liquid Biopsy Test for Patient Diagnosed with Non-Small Cell Lung Cancer PR Newswire +6.83%
Apr-27-18 08:05AM  Published Case Study Demonstrates the Clinical Utility of Biocept's Liquid Biopsy Test for ALK Rearrangements PR Newswire
Apr-06-18 08:05AM  Biocept to Webcast Presentation at the 7th Annual MicroCap Conference PR Newswire
07:40AM  Free Post Earnings Research Report: Exact Sciences Quarterly Revenues Jumped 148.02% ACCESSWIRE
Apr-03-18 08:05AM  Biocept to Present at the 7th Annual MicroCap Conference PR Newswire -13.35%
Mar-29-18 08:05AM  Biocept Obtains Patent for its Target Selector Molecular Biomarker Technology in China PR Newswire -7.81%
Mar-28-18 04:05PM  Biocept Reports 2017 Fourth Quarter and Full Year Financial Results PR Newswire
12:00PM  Biocept, Inc. to Host Earnings Call ACCESSWIRE
08:10AM  Biocept Inc, Liquid Biopsy is Coming, Analysts Review, Biopsy Market and Upcoming Milestones ACCESSWIRE
08:05AM  Biocept and Thermo Fisher Scientific Enter into Technology and Commercial Collaboration PR Newswire
Mar-20-18 08:05AM  Biocept to Present Recent Advances in Biomarker Identification from Liquid Biopsies at GTCbio's 11th Biomarker Summit PR Newswire
Mar-15-18 08:05AM  Biocept's Target Selector Platform Featured in Two Poster Presentations at the 2018 American Association for Cancer Research Annual Meeting PR Newswire
Mar-12-18 08:05AM  Biocept to Release 2017 Fourth Quarter and Full Year Financial Results and Host Investor Conference Call on March 28, 2018 PR Newswire
Mar-06-18 08:05AM  Biocept to Present at the 30th Annual ROTH Conference PR Newswire
Feb-05-18 08:05AM  Biocept Receives Additional Patent Issuances in Three Major International Territories for its Target Selector Platform PR Newswire -6.72%
Jan-31-18 05:16PM  Dawson James Securities Announces Closing of Approximately $14.78M Public Offering for Biocept, Inc. ACCESSWIRE
Jan-30-18 04:05PM  Biocept Announces Closing of $14.8 Million Public Offering of 32,854,606 Shares of Common Stock and Warrants to Purchase 32,854,606 Shares of Common Stock PR Newswire
08:05AM  Biocept Comments on Updated Consensus Medical Guidelines Recommending Liquid Biopsy for Profiling of Tumor Biomarkers to Assist with the Treatment of Patients with Lung Cancer PR Newswire
Jan-26-18 01:15PM  Biocept Inc (BIOC) Dilutes Shareholders a Second Time in Two Months SmarterAnalyst -26.76%
06:31AM  Biocept Announces Pricing of $15.0 Million Public Offering of 33,333,333 Shares of Common Stock and Warrants to Purchase 33,333,333 Shares of Common Stock PR Newswire
Jan-24-18 04:04PM  Colony NorthStar, Kimco Realty Slide into Wednesdays 52-Week Low Club 24/7 Wall St. -8.65%
Jan-17-18 01:45PM  Scientists seek super-shot for flu 100 years after pandemic Associated Press
08:59AM  Century after pandemic, science takes its best shot at flu Associated Press
Jan-09-18 08:05AM  Biocept Study Shows Incorporation of Thermo Fisher QuantStudio 5 PCR Instrument into Target Selector Platform Improves Sensitivity and Specificity in Detection of Lung Cancer Biomarkers PR Newswire
Jan-04-18 08:05AM  Biocept Obtains Patent in Australia for its Molecular Biomarker Technology For the Detection of Cancer-Associated Mutations in Blood, Tissue, and Other Biological Sources PR Newswire
Dec-28-17 11:52AM  ETFs with exposure to Biocept, Inc. : December 28, 2017 Capital Cube
Dec-19-17 11:47AM  GlaxoSmithKline (Egypt): Strong price momentum but will it sustain? Capital Cube
Dec-18-17 08:05AM  Biocept Signs In-Network Provider Agreement with Wellmark Blue Cross Blue Shield Expanding Coverage for its Target Selector Platform in Iowa and South Dakota PR Newswire
Dec-11-17 01:34PM  ETFs with exposure to Biocept, Inc. : December 11, 2017 Capital Cube -5.39%
Dec-06-17 12:53PM  What Spooked Biocept Inc (BIOC) Investors Today SmarterAnalyst -33.04%
Biocept, Inc., an early stage molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. The company's cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for targeted therapy at diagnosis, progression, and monitoring in order to identify resistance mechanisms. It offers assays for solid tumor indications, such as breast cancer, non-small cell lung cancer, small cell lung cancer, gastric cancer, colorectal cancer, prostate cancer, melanoma, pancreatic biliary cancer, and ovarian cancer. The company sells its cancer diagnostic assays directly to oncologists and other physicians at private and group practices, hospitals, and cancer centers in the United States, as well as markets its clinical trial and research services to pharmaceutical and biopharmaceutical companies, and clinical research organizations. Biocept, Inc. was founded in 1997 and is headquartered in San Diego, California.